Minimizing potential resistance: A population dynamics view

Clinical Infectious Diseases

Volumn 33, Issue SUPPL. 3, 2001, Pages

  Levin, B R ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA;

ANTIBIOTIC RESISTANCE; BACTERIAL GROWTH; BACTERIAL INFECTION; CONFERENCE PAPER; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; MATHEMATICAL MODEL; NONHUMAN; POPULATION DYNAMICS; POPULATION GENETICS; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HOSPITALS; HUMANS; MODELS, GENETIC; POPULATION DYNAMICS;

EID: 0035885022     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/321843     Document Type: Conference Paper

References (37)

1. Epidemiology of penicillin resistant pneumococci in Iceland
2. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study
3. Trends in antibiotic resistance of respiratory pathogens: An analysis and commentary on a collaborative surveillance study
4. The effect of changes in the consumption of macrolide antibiotics of erythromycin resistance in group A streptococci in Finland
5. Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci
6. Antibiotic usage and the incidence of resistance
7. The population genetics of antibiotic resistance
8. The population genetics of antibiotic resistance. II. Analytical theory for sustained populations of bacteria in a community of hosts
9. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance
10. Mathematical models of the emergence and spread of antibiotic resistance
11. Modeling and simulating the evolution of resistance against antibiotics
12. Continued decline in the incidence of penicillin nonsusceptible pneumococci in Iceland
13. Modification of prescribers' behavior: The Icelandic approach
14. Major change in the use of antibiotics following a national programme: Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA)
15. Provider and community education decreases antimicrobial use and carriage of penicillin resistant Streptococcus pneumoniae (PRSP)
16. The biological cost of antibiotic resistance
17. The epidemiology of antibiotic resistance in hospitals: Paradoxes and prescriptions
18. Modeling antibiotic resistance in the ICU: U.S. slant
19. Antimicrobial resistance in the intensive care unit: Impact of new patterns
20. Transmission dynamics of epidemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in England and Wales
21. Aminoglycoside resistance and aminoglycoside usage: Ten years of experience in one hospital
22. Does antibiotic restriction prevent resistance?
23. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes
24. The transmission dynamics of antibiotic-resistant bacteria: The relationship between resistance in commensal organisms and antibiotic consumption
25. Limiting the spread of penicillin-resistant Streptococcus pneumoniae: Experiences from the South Swedish Pneumococcal Intervention Project
26. Role of communicable disease control measures in affecting the spread of resistant pneumococci: The Swedish model
27. The tragedy of the commons
28. Effectiveness of a nationwide infant immunization program against Haemophilus influenzae b
29. Pneumococcal conjugate vaccines: Review and update
30. Vaccination against colonizing bacteria with multiple serotypes
31. Bacterial vaccines and serotype replacement: Lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae
32. Mathematical modelling of effectiveness
33. Vaccines and their impact on the control of disease
34. Evaluating treatment protocols to prevent antibiotic resistance
35. Vancomycin-resistant enterococci in intensive-care hospital settings: Transmission dynamics, persistence, and the impact of infection control programs
36. Limiting the spread of penicillin-resistant Streptococcus pneumoniae: Experiences from the South Swedish pneumococcal intervention project